|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.057 HKD | +3.64% |
|
+5.56% | +14.00% |
New Ray Medicine International Holding Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 335.38 million compared to HKD 133.21 million a year ago. Net loss was HKD 2.82 million compared to HKD 69.73 million a year ago.
Basic loss per share from continuing operations was HKD 0.0017 compared to HKD 0.0417 a year ago. Diluted loss per share from continuing operations was HKD 0.0017 compared to HKD 0.0417 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.00% | 11.77M | |
| -38.30% | 13.9B | |
| -33.50% | 10.68B | |
| +11.56% | 6.24B | |
| -11.61% | 5.96B | |
| +73.30% | 4.72B | |
| -3.65% | 4.56B | |
| -6.67% | 3.87B | |
| -19.00% | 3.17B | |
| -13.44% | 2.86B |
NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED 